|
LINS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.228400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.434200E-01 |
| Normal-vs-Stage2 |
4.175600E-01 |
| Normal-vs-Stage3 |
9.770600E-01 |
| Normal-vs-Stage4 |
2.388000E-01 |
| Stage1-vs-Stage2 |
3.364000E-01 |
| Stage1-vs-Stage3 |
9.354000E-01 |
| Stage1-vs-Stage4 |
3.673400E-01 |
| Stage2-vs-Stage3 |
4.419400E-01 |
| Stage2-vs-Stage4 |
1.325820E-01 |
| Stage3-vs-Stage4 |
4.377400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.219400E-01 |
| Normal-vs-AfricanAmerican |
4.604000E-01 |
| Normal-vs-Asian |
4.176200E-01 |
| Caucasian-vs-AfricanAmerican |
2.658000E-01 |
| Caucasian-vs-Asian |
4.840600E-01 |
| AfricanAmerican-vs-Asian |
7.796400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.965000E-01 |
| Normal-vs-Female |
9.958000E-01 |
| Male-vs-Female |
8.885800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.573000E-01 |
| Normal-vs-Extreme_Weight |
8.422000E-01 |
| Normal-vs-Obese |
6.667600E-01 |
| Normal-vs-Extreme_Obese |
5.466400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.770600E-01 |
| Normal_Weight-vs-Obese |
5.028000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.768600E-01 |
| Extreme_Weight-vs-Obese |
5.205800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.871000E-01 |
| Obese-vs-Extreme_Obese |
4.906000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.613200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.460400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.782400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.221810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.467200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.204600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.919400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.276800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.411600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.080400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.253400E-01 |
| Normal-VS-Type2 PRCC |
3.211800E-01 |
| Normal-VS-KIRP CIMP |
1.433910E-02 |
| Normal-VS-Unclassified PRCC |
3.676600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.691700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.917890E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.449800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.809600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.020020E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.418500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.004000E-01 |
| Normal-vs-N1 |
8.766400E-01 |
| Normal-vs-N2 |
3.680500E-02 |
| N0-vs-N1 |
9.052800E-01 |
| N0-vs-N2 |
1.597360E-01 |
| N1-vs-N2 |
2.145000E-01 |
|
|
